Docetaxel combined with oral etoposide as second-line treatment for advanced gastric carcinoma after failure of platinum- and fluoropyrimidine-based regimens.


YILDIZ R., KALENDER M., DANE F., SEVINC A., Gumus M. , CAMCI C., et al.

Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, cilt.16, ss.173-8, 2010

  • Cilt numarası: 16
  • Basım Tarihi: 2010
  • Doi Numarası: 10.1177/1078155209347402
  • Dergi Adı: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
  • Sayfa Sayısı: ss.173-8